Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2022 - 05 - 09 source : Www.biospace.com save search
Nuvation Bio Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-09 (Crawled : 22:00) - biospace.com/
NUVB A | $2.655 -1.3% 150K
|
|
| O: -2.66%
H: 0.68%
C: -3.64%
results
Precigen Reports First Quarter 2022 Financial Results and Business Updates
Published: 2022-05-09 (Crawled : 22:00) - biospace.com/
PGEN | $1.315 0.38% 190K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -8.0%
results
Novavax Reports First Quarter 2022 Financial Results and Operational Highlights
Published: 2022-05-09 (Crawled : 22:00) - biospace.com/
TAK | $13.2 0.38% 90K
|
Health Technology
|
| O: -0.69%
H: 0.28%
C: -1.1%
NVAX | $3.93 1.03% 650K
|
Health Technology
|
| O: 0.09%
H: 5.27%
C: -7.13%
results
Castle Biosciences Reports First Quarter 2022 Results
Published: 2022-05-09 (Crawled : 21:00) - biospace.com/
CSTL | $19.03 1.01% 8.9K
|
Health Technology
|
| O: -3.31%
H: 0.0%
C: 0.0%
results bioscience
Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress
Published: 2022-05-09 (Crawled : 21:00) - biospace.com/
TAK | $13.2 0.38% 90K
|
Health Technology
|
| O: -0.69%
H: 0.28%
C: -1.1%
JNJ | News | $145.08 0.21% 2M
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: 0.0%
ARCT 4 | $26.97 -2.42% 110K
|
Health Technology
|
| O: -2.88%
H: 2.34%
C: -8.64%
therapeutics
Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Recent Corporate Updates
Published: 2022-05-09 (Crawled : 21:00) - biospace.com/
HRTX | $2.85 2.89% 450K
|
Health Technology
|
| O: -1.7%
H: 1.36%
C: -10.64%
therapeutics
Inhibrx Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
Published: 2022-05-09 (Crawled : 21:00) - biospace.com/
INBX | $34.66 0.14% 150K
|
Health Technology
|
| O: -3.66%
H: 6.6%
C: -2.67%
results
Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study
Published: 2022-05-09 (Crawled : 21:00) - biospace.com/
RCUS 4 | $14.66 -1.21% 100K
|
Health Technology
|
| O: -1.63%
H: 2.58%
C: 1.9%
arcus
IGM Biosciences Announces First Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-05-09 (Crawled : 21:00) - biospace.com/
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
IGMS | News | $7.65 -5.9% 40K
|
Health Technology
|
| O: -1.26%
H: 2.95%
C: -11.11%
results
Vaxcyte Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-09 (Crawled : 21:00) - biospace.com/
PPRUF | News | $361.9 4.3K
|
Consumer Non-Durables
|
| O: -0.12%
H: 0.5%
C: -4.16%
PPRUY | News | $36.03 330K
|
Manufacturing
|
| O: -2.22%
H: 0.4%
C: -1.38%
DHR | $235.35 -1.69% 1.1M
|
Health Technology
|
| O: -1.74%
H: 0.98%
C: -2.24%
PCVX | $60.955 -2.36% 77K
|
Health Technology
|
| O: -1.4%
H: 2.32%
C: -10.53%
STRO M | $3.73 -1.84% 65K
|
Health Technology
|
| O: 1.05%
H: 1.04%
C: -12.98%
results
Arcellx Announces Publication in Blood Advances of Clinical Results from the Dose Escalation Cohorts of its CART-ddBCMA Phase 1 Study in Patients with Relapsed or Refractory Multiple Myeloma
Published: 2022-05-09 (Crawled : 21:00) - biospace.com/
ACLX | $53.77 0.41% 59K
|
|
| O: -3.37%
H: 7.32%
C: -4.05%
blood results publication phase 1
HOOKIPA Pharma to Report First Quarter 2022 Financial Results on May 16, 2022
Published: 2022-05-09 (Crawled : 20:00) - biospace.com/
HOOK | $0.779 2.16% 47K
|
Health Technology
|
| O: -2.74%
H: 2.11%
C: -6.34%
pharma report results
COMPASS Pathways to fund study of COMP360 psilocybin in autistic adults
Published: 2022-05-09 (Crawled : 19:00) - biospace.com/
CMPS | $8.665 1.58% 42K
|
Health Technology
|
| O: -1.69%
H: 0.0%
C: -9.8%
comp360 psilocybin
Janssen Dissolves HPV, HBV Collaboration with Bavarian Nordic
Published: 2022-05-09 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.08 0.21% 2M
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: 0.0%
collaboration
Amicus Therapeutics Announces First Quarter 2022 Financial Results
Published: 2022-05-09 (Crawled : 14:20) - biospace.com/
FOLD F | $10.445 -1.0% 130K
|
Health Technology
|
| O: -9.35%
H: 14.81%
C: 3.66%
therapeutics results
Tonix Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights
Published: 2022-05-09 (Crawled : 14:20) - biospace.com/
TNXP | $0.1582 -0.75% 430K
|
Health Technology
|
| O: -8.56%
H: 3.92%
C: -0.23%
results
BioXcel Therapeutics Reports First Quarter 2022 Financial Results and Recent Operational Highlights
Published: 2022-05-09 (Crawled : 14:20) - biospace.com/
BTAI | $2.58 -0.39% 110K
|
Health Technology
|
| O: -1.75%
H: 3.48%
C: -7.94%
therapeutics results
Humacyte to Provide Human Acellular Vessels™ (HAVs™) to Front-line Hospitals in Ukraine for Treatment of Vascular Trauma Injuries
Published: 2022-05-09 (Crawled : 14:20) - biospace.com/
HUMA | $3.205 2.72% 320K
|
Manufacturing
|
| O: -2.23%
H: 2.12%
C: -7.17%
treatment
Chimerix to Report First Quarter 2022 Financial Results and Provide an Operational Update on May 16, 2022
Published: 2022-05-09 (Crawled : 14:20) - biospace.com/
CMRX | $0.9032 -0.09% 50K
|
Health Technology
|
| O: -1.31%
H: 2.43%
C: -13.72%
report results
MoonLake Immunotherapeutics announces the publication of new long-term disease control data from a Phase 2b Psoriasis trial of the Nanobody® sonelokimab
Published: 2022-05-09 (Crawled : 14:00) - biospace.com/
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
nanobody disease control trial psoriasis publication phase 2b
Gainers vs Losers
| 80% | 20% |
Top 10 Gainers
TIRX | $1.13 133.09% 44M
|
AGBA | $0.8978 124.45% 60M
|
Finance
BPTH | $6.18 90.74% 39M
|
Health Technology
INVO | $1.44 89.47% 3M
|
Health Technology
XPON | $2.66 37.82% 5.2M
|
SINT | $0.0504 35.12% 300M
|
Health Technology
THCH | $1.38 32.69% 9.9M
|
n/a
ALRN | $5.605 31.88% 210K
|
Health Technology
HOLO | $2.92 30.36% 22M
|
SMSI 4 | $2.53 29.74% 510K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.